Stay updated with breaking news from Roche Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
On October 26, 2023, Genentech, a member of the Roche Group, announced that the FDA approved VABYSMO (faricimab-svoa) for the treatment of macular edema following retinal vein...
06.11.2023 - Positive clinical data updates across multiple drug classes including antibody-drug conjugate (ADC) candidates BNT323/DB-1303, BNT325/DB-1305, CAR-T candidate BNT211, T cell therapy candidate BNT221 and mRNA cancer vaccine candidate BNT116Progress ...
-- Disclosure of eIF4E, a regulator of oncoprotein translation, as target of most advanced program ---- Data demonstrate strong in vivo anti-tumor effects of orally bioavailable small molecules; IND enabling studies planned ---- Additional data to be presented at San Antonio Breast Cancer Symposium in early December...
PARIS--(BUSINESS WIRE)--Nov 6, 2023--
AC Immune to Host KOL Webinar on Amyloid Plaque PET Imaging in Alzheimer’s Disease as a Surrogate of Clinical Efficacy on November 9, 2023 Lausanne, Switzerland, November 02, 2023 – AC Immune...